| IBSA Institut Biochimique SA - Condromed 200 mg / 250 mg, Hartkapseln |
| 68626 | | 01 | | Condromed 200 mg / 250 mg | | Hartkapseln | | M01CX | | Other Specific Antirheumatic Agents | | 11.01.2023 | | |
|
| Composition |
| glucosamini hydrochloridum 250 mg, chondroitini sulfas natricus 200 mg corresp. natrium 18 mg, magnesii stearas, materiale di capsula: gelatina, E 132, E 171, pro capsula. |
| Packungsbestandteile |
| Capsules | | | | Active Agent | Dose |
|---|
| Chondroitine Sodium Sulfate | 200 mg correspond Sodium 18 mg | | Glucosamini Hydrochloridum | 250 mg |
| | | | Inactive agents | | additional_information |
|---|
| E 132 | | color. | | E 171 | | color. | | Gelatina | | materiale di capsula | | Magnesii Stearas | | | | Pro Capsula | | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 90 | PR | PR | B | | No |
|
